X

ACB

Aurora Decreases Potential Stock Issuance to $250M From $350M

We previously reported on Aurora Cannabis' plans to raise more capital in an at-the-market equity program valued at around $350M.…

The Post Roll: Earnings – Aphria, Organigram, Aurora & Valens

In this edition of The Post Roll, Thomas George and Scott Willis review the flurry of earnings releases in the…

What Does Aurora Cannabis’ 12-for-1 Reverse Stock Split Mean for You

Aurora Cannabis (TSE:ACB, NYSE:ACB) has announced a 12-to-1 consolidation (otherwise known as a reverse split) of its common shares effective…

Marijuana Investor Roundup: Analysis of the Week’s Most Important Events (Apr 12th, 2020)

Post-Roll: Bull Market in Vice Stocks  Bottom Line: With much of the global population stuck indoors, we are already seeing…

Marijuana Investor Roundup: Analysis of the Week’s Most Important Events (Apr 4th, 2020)

The Post-Roll: Which Pot Stock is Going Bust Next (ACB, HARV) Bottom Line: In this special edition of the Grizzle…

Pot Stocks Post-Roll: Who’s Next to Kick the Bankruptcy Bucket?

With two cannabis restructurings announced in one day, it got us thinking. Is the day of reckoning finally here for…

The Post Roll: Value Case for Trulieve (TRUL) & Toxic Pot Stocks

https://youtu.be/pxI_7y698rs Scott Willis and Thomas George take stock of the battered down cannabis sector, even though sales have picked up…

Marijuana Investor Roundup: Analysis of the Week’s Most Important Events (Mar 21st, 2020)

Aurora Cannabis Founder Terry Booth Goes on a Selling Spree Bottom Line: The fact that Terry Booth was willing to…

Tilray Announces Write-offs, Big Revenue Miss in Q4

Legal cannabis producer Tilray (NASDAQ: TLRY) reported disappointing results and the stock is down 10% as of 4:40 EST in…